A genome-wide linkage analysis in 181 German sarcoidosis families using clustered biallelic markers

Chest

Volumn 138, Issue 1, 2010, Pages 151-157

  Fischer, Annegret ^a   Nothnagel, Michael ^a   Schürmann, Manfred ^b   Müller Quernheim, Joachim ^c   Schreiber, Stefan ^a   Hofmann, Sylvia ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME; FAMILY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77954754916     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2526     Document Type: Article

References (36)

1. Sverrild A, Backer V, Kyvik KO, et al. Heredity in sarcoidosis: a registry-based twin study. Thorax. 2008;63(10):894-896.
2. Statement on Sarcoidosis. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736-755.
3. Zissel G, Prasse A, Müller-Quernheim J. Sarcoidosis - immunopathogenetic concepts. Semin Respir Crit Care Med. 2007;28(1):3-14.
4. Müller-Quernheim J, Schürmann M, Hofmann S, et al. Genetics of sarcoidosis. Clin Chest Med. 2008;29(3):391-414.
5. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153-2165.
6. Schürmann M, Reichel P, Müller-Myhsok B, Schlaak M, Müller-Quernheim J, Schwinger E. Results from a genomewide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med. 2001;164(5):840-846. (Pubitemid 32881922)
7. Iannuzzi MC, Iyengar SK, Gray-McGuire C, et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. 2005;6(6):509-518.
8. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet. 2005;37(4):357-364.
9. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC; ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet. 2005;77(3):491-499. (Pubitemid 41192655)
10. Hofmann S, Franke A, Fischer A, et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet. 2008;40(9):1103-1106.
11. Franke A, Fischer A, Nothnagel M, et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology. 2008;135(4):1207-1215.
12. Iannuzzi MC. Genetics of sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):15-21.
13. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273(5281):1516-1517. (Pubitemid 26301653)
14. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39(2):207-211. (Pubitemid 46184351)
15. Abecasis GR, Wigginton JE. Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers. Am J Hum Genet. 2005;77(5):754-767.
16. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11(3):241-247.
17. Rybicki BA, Major M, Popovich JJ Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234-241.
18. Rossman MD, Thompson B, Frederick M, et al; ACCESS Group. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73(4):720-735.
19. Baughman RP, Teirstein AS, Judson MA, et al; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 pt 1):1885-1889.
20. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med. 2007;357(12):1199-1209.
21. Kurreeman FA, Goulielmos GN, Alizadeh BZ, et al. The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases. Ann Rheum Dis. 2010;69:696-699.
22. Gasque P. Complement: a unique innate immune sensor for danger signals. Mol Immunol. 2004;41(11):1089-1098. (Pubitemid 39345390)
23. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J. 2009;23(6):1625-1637.
24. Waschke KA, Villani A-C, Vermeire S, et al. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes. Am J Gastroenterol. 2005;100(5):1126-1133. (Pubitemid 40769052)
25. Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis. 1996;23(1):146-158.
26. Pabst S, Karpushova A, Dìaz-Lacava A, et al. VEGF gene haplotypes are associated with sarcoidosis. Chest. 2010;137(1):156-163.
27. Grunewald J, Eklund A. Löfgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med. 2009;179(4):307-312.
28. Fischer A, Valentonyte R, Nebel A, et al. Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Löfgren's syndrome. J Mol Med. 2008;86(5):553-561.
29. Brown L, Ongusaha PP, Kim H-G, et al. CDIP, a novel proapoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner. EMBO J. 2007;26(14):3410-3422. (Pubitemid 47123544)
30. Swanberg M, Lidman O, Padyukov L, et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet. 2005;37(5):486-494.
31. Martinez A, Perdigones N, Cenit M, et al. Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis. 2010;69(1):309-311.
32. Krawczyk M, Reith W. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. Tissue Antigens. 2006;67(3):183-197. (Pubitemid 43383366)
33. Evans DM, Cardon LR. Guidelines for genotyping in genomewide linkage studies: single-nucleotide-polymorphism maps versus microsatellite maps. Am J Hum Genet. 2004;75(4):687-692.
34. Ulgen A, Li W. Comparing single-nucleotide polymorphism marker-based and microsatellite marker-based linkage analyses. BMC Genet. 2005;6(suppl 1):S13.
35. John S, Shephard N, Liu G, et al. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet. 2004;75(1):54-64.
36. Middleton FA, Pato MT, Gentile KL, et al. Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet. 2004;74(5):886-897.